EORTC Cancer in the Elderly Task Force investigates appropriate treatment for elderly patients

As we age, we experience a progressive decline in many of our bodily functions. This decline can vary greatly from individual to individual. One 75 year old might still be very active and participate in strenuous physical activities, while another might require considerable assistance just to perform simple everyday tasks. Aging is variable. It is a highly individualized process that is influenced by a number of genetic, developmental, and environmental factors.

Many things, not simply chronological age, contribute to treatment tolerance and outcome in older patients with cancer, and these present challenges when determining appropriate treatment. Recently, though, members of the EORTC Cancer in the Elderly Task Force, in a paper published in the Journal of Geriatric Oncology, evaluated the physiological reserves of with cancer and described the most relevant biomarkers that might potentially serve to indicate their functional biological age.

Dr. Hans Wildiers of the University Hospitals Leuven, Chair of the Cancer in the Elderly Task Force, and co-author of this study, says, "The incidence of most malignant diseases increases with age. Studies have shown that slightly more than half of all newly diagnosed cancer cases and more than two thirds of cancer-related deaths occur in patients 65 years or older. So, we expect the number of older patients with will increase as the population ages. Doctors will increasingly need to make treatment decisions for , and to make effective decisions, we will need better biological markers of aging."

The EORTC Cancer in the Elderly Task Force study provides a guideline on integrating several potential biomarkers of aging: inflammatory markers, telomere length and telomerase activity, genetic predisposition for longevity, of aging related genes in peripheral blood mononuclear cell, immunosenescence, lymphocyte senescence p16INK4a expression in T lymphocytes, and plasma microRNA expression profile.

They point out that comprehensive geriatric assessment can provide information on the general health status of individuals, but that it is far from perfect as a prognostic or predictive tool for individual patients. Alternatively, biological changes in certain tissues which are the result of adaptive alterations due to past exposures as well as the can help to assess aging.

Provided by European Organisation for Research and Treatment of Cancer

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Linking risk factors and disease origins in breast cancer

Nov 20, 2013

Researchers from the Geisel School of Medicine at Dartmouth have found that epigenetic changes to DNA are associated with aging in disease-free breast tissues and are further altered in breast tumors. Epigenetic changes describe ...

Tipping the balance between senescence and proliferation

Nov 15, 2013

An arrest in cell proliferation, also referred to as cellular senescence, occurs as a natural result of aging and in response to cellular stress. Senescent cells accumulate with age and are associated with many aging phenotypes, ...

Population aging crisis may have been overestimated

Nov 13, 2013

(HealthDay)—Use of an alternative measure for assessing the number of dependent older people suggests that the population aging crisis may have been overestimated, according to an analysis published online ...

Recommended for you

Discovery could lead to new cancer treatment

7 hours ago

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

Is the HPV vaccine necessary?

13 hours ago

As the school year starts in full swing many parents wonder if their child should receive the HPV vaccine, which is recommended for girls ages 11-26 and boys 11-21. There are a lot of questions and controversy around this ...

User comments